Guardion Health Sciences, Inc. (NASDAQ:GHSI) was the target of a significant decline in short interest during the month of August. As of August 31st, there was short interest totalling 196,400 shares, a decline of 42.7% from the August 15th total of 342,900 shares. Based on an average daily volume of 306,600 shares, the short-interest ratio is currently 0.6 days.
GHSI stock remained flat at $$1.22 during midday trading on Friday. The company’s stock had a trading volume of 197,599 shares, compared to its average volume of 2,062,387. The company’s 50-day moving average is $1.32 and its 200-day moving average is $1.72. Guardion Health Sciences has a twelve month low of $0.99 and a twelve month high of $8.40. The stock has a market cap of $29.80 million, a PE ratio of -1.82 and a beta of 0.05.
Guardion Health Sciences (NASDAQ:GHSI) last posted its quarterly earnings data on Monday, August 16th. The company reported ($0.10) earnings per share for the quarter. Guardion Health Sciences had a negative return on equity of 41.67% and a negative net margin of 666.39%. The business had revenue of $1.22 million during the quarter.
Guardion Health Sciences Company Profile
Guardion Health Sciences, Incis a clinical nutrition and diagnostics company, which develops medical foods and medical devices in the ocular health space and develops nutraceutical products to provide supportive health benefits to consumers. The firm operates through the following segments Medical Foods and Nutraceuticals & Medical Devices.
Featured Article: Growth and Income Funds
Receive News & Ratings for Guardion Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardion Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.